Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility StudyLaetitia E. Lamberts, Gooitzen M. van Dam, Maximillian Koch et al.|Clinical Cancer Research|2016Cited by 289
<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic TreatmentSjoukje F. Oosting, Elisabeth G.E. de Vries, Adrienne H. Brouwers et al.|Journal of Nuclear Medicine|2014Cited by 114
Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp DetectionJolien J. Tjalma, Wouter B. Nagengast, P. Beatriz García-Allende et al.|Journal of Nuclear Medicine|2015Cited by 70
VEGF-SPECT with 111In-bevacizumab in stage III/IV melanoma patientsWouter B. Nagengast, Geke A.P. Hospers, Marjolijn N. Lub–de Hooge et al.|European Journal of Cancer|2011Cited by 55
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Vasilis Ntziachristos, Carolien P. Schröder et al.|Cancer Research|2016Cited by 43